Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GLP-1 Effect on Prandial Motility
NCT02731664Phase 1Completed
- Sponsor
- Uppsala University
- Start
- Sep 2012
- Primary completion
- Aug 2017
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Glucagon-like peptide 1 in functional gastrointestinal disorders (FGID), sponsored by Uppsala University. Primary endpoint: Motility index at 60 minutes. Started Sep 2012; status: completed.
02
Drugs
Glucagon-like peptide 1
03
Conditions
functional gastrointestinal disorders (FGID)
Beyond the preview
Go deeper on NCT02731664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02731664.